Paper68278
Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease.
Davies TF and 5 others. Lancet, 1977. Cited by 144 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Papers, record 68278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68278
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Graves Disease | Major topic |
| Thyroid Gland | Major topic |
| Adult | |
| Antithyroid Agents | |
| Female | |
| Humans | |
| Prognosis | |
| Recurrence |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,622,195 | The evolving therapeutic landscape of Graves' disease in adults: present and future. | Eur Thyroid J | 2025 | https://conductscience.org/library/papers/40622195 | PubMed |
| 37,876,493 | Methimazole, an Effective Neutralizing Agent of the Sulfur Mustard Derivative 2-Chloroethyl Ethyl Sulfide. | ACS Bio Med Chem Au | 2023 | https://conductscience.org/library/papers/37876493 | PubMed |
| 37,627,966 | Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA). | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37627966 | PubMed |
| 36,514,581 | Utility of Antibodies in the Diagnoses of Thyroid Diseases: A Review Article. | Cureus | 2022 | https://conductscience.org/library/papers/36514581 | PubMed |
| 36,129,592 | 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease. | Endocrine | 2023 | https://conductscience.org/library/papers/36129592 | PubMed |
| 29,456,513 | Stochastic Effects in Autoimmune Dynamics. | Front Physiol | 2018 | https://conductscience.org/library/papers/29456513 | PubMed |
| 23,539,719 | Clinical review: Clinical utility of TSH receptor antibodies. | J Clin Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23539719 | PubMed |
| 6,896,520 | Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/6896520 | PubMed |
| 6,699,171 | Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6699171 | PubMed |
| 6,147,377 | 10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb). | J Endocrinol Invest | 1984 | https://conductscience.org/library/papers/6147377 | PubMed |
| 6,139,399 | The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. | J Endocrinol Invest | 1983 | https://conductscience.org/library/papers/6139399 | PubMed |
| 6,138,364 | Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6138364 | PubMed |
| 2,900,851 | Measurement of TSAb directly in serum using FRTL-5 cells. | J Endocrinol Invest | 1988 | https://conductscience.org/library/papers/2900851 | PubMed |
| 2,573,625 | Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year. | J Endocrinol Invest | 1989 | https://conductscience.org/library/papers/2573625 | PubMed |
| 2,422,245 | Changes in thyrotropin binding inhibiting immunoglobulins (TBII) in sera of patients with Graves' disease at the time of relapse or exacerbation. | J Endocrinol Invest | 1986 | https://conductscience.org/library/papers/2422245 | PubMed |
| 2,421,862 | Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease. | CMAJ | 1986 | https://conductscience.org/library/papers/2421862 | PubMed |
| 1,283,984 | Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. | J Endocrinol Invest | 1992 | https://conductscience.org/library/papers/1283984 | PubMed |
| 582,828 | Interference of thyroglobulin in TSab detection by radio-receptor assay. | J Endocrinol Invest | 1979 | https://conductscience.org/library/papers/582828 | PubMed |
| 227,717 | TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism. | Experientia | 1979 | https://conductscience.org/library/papers/227717 | PubMed |
| 90,689 | Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? | J Endocrinol Invest | 1978 | https://conductscience.org/library/papers/90689 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68278
GET https://conductscience.org/api/papers/v1/68278/cited_by?page=2